EFAVIRENZ — all Canadian products
17 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is EFAVIRENZ, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02468247 | APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | APOTEX INC | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02418428 | AURO-EFAVIRENZ | AURO PHARMA INC | Tablet | Oral | EFAVIRENZ 600 MG | Marketed | |
| 02478404 | AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | AURO PHARMA INC | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02519461 | JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | JAMP PHARMA CORPORATION | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02381524 | MYLAN-EFAVIRENZ | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | EFAVIRENZ 600 MG | Marketed | |
| 02461412 | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02389762 | TEVA-EFAVIRENZ | TEVA CANADA LIMITED | Tablet | Oral | EFAVIRENZ 600 MG | Marketed | |
| 02393549 | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | TEVA CANADA LIMITED | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02300699 | ATRIPLA | GILEAD SCIENCES, LLC | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Cancelled Post Market | |
| 02458233 | JAMP-EFAVIRENZ | JAMP PHARMA CORPORATION | Tablet | Oral | EFAVIRENZ 600 MG | Dormant | |
| 02487284 | PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | PHARMASCIENCE INC | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Dormant | |
| 02518716 | RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | LABORATOIRE RIVA INC. | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Cancelled Post Market | |
| 02484676 | SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR | SANDOZ CANADA INCORPORATED | Tablet | Oral | EFAVIRENZ 600 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Cancelled Post Market | |
| 02239887 | SUSTIVA 100MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | EFAVIRENZ 100 MG | Cancelled Post Market | |
| 02239888 | SUSTIVA 200MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | EFAVIRENZ 200 MG | Cancelled Post Market | |
| 02239886 | SUSTIVA 50MG | BRISTOL-MYERS SQUIBB CANADA | Capsule | Oral | EFAVIRENZ 50 MG | Cancelled Post Market | |
| 02246045 | SUSTIVA TABLETS | BRISTOL-MYERS SQUIBB CANADA | Tablet | Oral | EFAVIRENZ 600 MG | Cancelled Post Market |
Browse other molecules: